{"id":"https://openalex.org/W2581807473","doi":"https://doi.org/10.1111/dom.12888","title":"Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone","display_name":"Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone","alternate_titles":[],"publication_year":2017,"publication_date":"2017-02-22","ids":{"openalex":"https://openalex.org/W2581807473","doi":"https://doi.org/10.1111/dom.12888","mag":"2581807473","pmid":"https://pubmed.ncbi.nlm.nih.gov/28116776"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12888","doi":"https://doi.org/10.1111/dom.12888","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12888","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2581807473"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000786302","display_name":"Steven G. Terra","orcid":"https://orcid.org/0000-0002-5815-6193","observed_orcids":["https://orcid.org/0000-0002-5815-6193"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Steven G. Terra","raw_affiliation_strings":["Pfizer, Andover, Massachusetts"],"raw_orcid":"https://orcid.org/0000-0002-5815-6193","affiliations":[{"raw_affiliation_string":"Pfizer, Andover, Massachusetts","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028824765","display_name":"Kristen Focht","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kristen Focht","raw_affiliation_strings":["Pfizer, Collegeville, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084593004","display_name":"Melanie Jane Davies","orcid":"https://orcid.org/0000-0002-9987-9371","observed_orcids":["https://orcid.org/0000-0002-9987-9371"]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Melanie Davies","raw_affiliation_strings":["Diabetes Research Centre, University of Leicester, Leicester, UK"],"raw_orcid":"https://orcid.org/0000-0002-9987-9371","affiliations":[{"raw_affiliation_string":"Diabetes Research Centre, University of Leicester, Leicester, UK","institution_ids":["https://openalex.org/I153648349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086072427","display_name":"Juan P. Fr\u00edas","orcid":"https://orcid.org/0000-0001-9486-1255","observed_orcids":["https://orcid.org/0000-0001-9486-1255"]},"institutions":[{"id":"https://openalex.org/I4210111119","display_name":"National Research Institute","ror":"https://ror.org/02201aj62","country_code":"US","type":"other","lineage":["https://openalex.org/I4210111119"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Juan Frias","raw_affiliation_strings":["National Research Institute, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Institute, Los Angeles, California","institution_ids":["https://openalex.org/I4210111119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021841408","display_name":"Giuseppe Derosa","orcid":"https://orcid.org/0000-0003-3573-4760","observed_orcids":["https://orcid.org/0000-0003-3573-4760"]},"institutions":[{"id":"https://openalex.org/I25217355","display_name":"University of Pavia","ror":"https://ror.org/00s6t1f81","country_code":"IT","type":"education","lineage":["https://openalex.org/I25217355"]},{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giuseppe Derosa","raw_affiliation_strings":["University of Pavia and IRCCS Policlinico San Matteo Foundation, Pavia, Italy"],"raw_orcid":"https://orcid.org/0000-0003-3573-4760","affiliations":[{"raw_affiliation_string":"University of Pavia and IRCCS Policlinico San Matteo Foundation, Pavia, Italy","institution_ids":["https://openalex.org/I25217355","https://openalex.org/I4210151645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103777229","display_name":"Amanda Darekar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amanda Darekar","raw_affiliation_strings":["Pfizer Ltd, Tadworth, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Ltd, Tadworth, UK","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021756822","display_name":"Gregory T. Golm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gregory Golm","raw_affiliation_strings":["Merck & Co., Inc. Kenilworth New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc. Kenilworth New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112247797","display_name":"Jeremy R. Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeremy Johnson","raw_affiliation_strings":["Merck & Co., Inc. Kenilworth New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc. Kenilworth New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044286485","display_name":"Didier Saur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118061","display_name":"Pfizer (France)","ror":"https://ror.org/02c9yny10","country_code":"FR","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210118061"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Didier Saur","raw_affiliation_strings":["Pfizer, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Paris, France","institution_ids":["https://openalex.org/I4210118061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042430242","display_name":"Brett P. Lauring","orcid":"https://orcid.org/0000-0002-9680-7452","observed_orcids":["https://orcid.org/0000-0002-9680-7452"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brett Lauring","raw_affiliation_strings":["Merck & Co., Inc. Kenilworth New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc. Kenilworth New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033587716","display_name":"Samuel E. Dagogo-Jack","orcid":"https://orcid.org/0000-0001-5318-9677","observed_orcids":["https://orcid.org/0000-0001-5318-9677"]},"institutions":[{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sam Dagogo\u2010Jack","raw_affiliation_strings":["University of Tennessee Health Sciences Center, Memphis, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tennessee Health Sciences Center, Memphis, Tennessee","institution_ids":["https://openalex.org/I160606119"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5000786302"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":14.5136,"has_fulltext":false,"cited_by_count":158,"citation_normalized_percentile":{"value":0.99473154,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"19","issue":"5","first_page":"721","last_page":"728"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ertugliflozin","display_name":"ertugliflozin","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.972000002861023},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.7440000176429749},{"id":"https://openalex.org/keywords/inadequate-glycaemic-control","display_name":"inadequate glycaemic control","score":0.8479999899864197},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8859999775886536},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.7070000171661377},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.9850000143051147},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.9679999947547913},{"id":"https://openalex.org/keywords/genital-mycotic-infections","display_name":"genital mycotic infections","score":0.9150000214576721},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8489999771118164},{"id":"https://openalex.org/keywords/urinary-tract-infection","display_name":"urinary tract infection","score":0.8539999723434448},{"id":"https://openalex.org/keywords/hypovolemia","display_name":"hypovolemia","score":0.8500000238418579},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.6809999942779541},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7670000195503235}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9472064971923828},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7616173028945923},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.6523566842079163},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5983165502548218},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5522255897521973},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5286814570426941},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5247804522514343},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4966157078742981},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4446370601654053},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.42886751890182495},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3993581533432007},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34205731749534607},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.18762800097465515},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.13999450206756592},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D003927","descriptor_name":"Diet, Diabetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009181","descriptor_name":"Mycoses","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009181","descriptor_name":"Mycoses","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D009181","descriptor_name":"Mycoses","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015444","descriptor_name":"Exercise","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018928","descriptor_name":"Immunity, Mucosal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D049990","descriptor_name":"Membrane Transport Modulators","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D049990","descriptor_name":"Membrane Transport Modulators","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D049990","descriptor_name":"Membrane Transport Modulators","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D050177","descriptor_name":"Overweight","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D050177","descriptor_name":"Overweight","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D050177","descriptor_name":"Overweight","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050177","descriptor_name":"Overweight","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D051297","descriptor_name":"Sodium-Glucose Transporter 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D060737","descriptor_name":"Reproductive Tract Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D060737","descriptor_name":"Reproductive Tract Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D060737","descriptor_name":"Reproductive Tract Infections","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.12888","doi":"https://doi.org/10.1111/dom.12888","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12888","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:28116776","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28116776","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320309117","display_name":"AbbVie","ror":"https://ror.org/02g5p4n58"},{"id":"https://openalex.org/F4320324757","display_name":"European Association for the Study of Diabetes","ror":"https://ror.org/04v0v0306"},{"id":"https://openalex.org/F4320337601","display_name":"Janssen Pharmaceuticals","ror":"https://ror.org/03qd7mz70"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W205475240","https://openalex.org/W1844817513","https://openalex.org/W1957004156","https://openalex.org/W1990025047","https://openalex.org/W1996042816","https://openalex.org/W2024372370","https://openalex.org/W2030311010","https://openalex.org/W2055033530","https://openalex.org/W2066259921","https://openalex.org/W2068171948","https://openalex.org/W2114276479","https://openalex.org/W2116974726","https://openalex.org/W2122633654","https://openalex.org/W2137069992","https://openalex.org/W2301210108","https://openalex.org/W2328718696","https://openalex.org/W2465112930","https://openalex.org/W2509533611","https://openalex.org/W4212932248","https://openalex.org/W4214858146"],"related_works":["https://openalex.org/W2790160447","https://openalex.org/W2752384709","https://openalex.org/W2944815545","https://openalex.org/W2754339077","https://openalex.org/W6902617302","https://openalex.org/W2908815907","https://openalex.org/W2055033530","https://openalex.org/W2918296699","https://openalex.org/W4402766011","https://openalex.org/W3012577282"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"conduct":[2],"a":[3,27,35,44],"phase":[4,79],"III":[5],"study":[6,33],"to":[7,68,97],"evaluate":[8],"the":[9,84,91,104,118,145,154,215],"efficacy":[10],"and":[11,54,75,115,121,148,166,171,199,235,249],"safety":[12],"of":[13,135,159,192,217],"ertugliflozin":[14,119,146,160,203],"monotherapy":[15],"in":[16,51,83,93,144,177,181,197,214],"people":[17],"with":[18,34,59,153,202,205,219,226],"type":[19],"2":[20],"diabetes.":[21],"MATERIALS":[22],"AND":[23],"METHODS:":[24],"This":[25],"was":[26,90,208],"52-week,":[28],"double-blind,":[29],"multicentre,":[30],"randomized,":[31],"parallel-group":[32],"26-week,":[36],"placebo-controlled":[37],"treatment":[38,47,238],"period":[39,48],"(phase":[40,49],"A),":[41],"followed":[42],"by":[43],"26-week":[45],"active-controlled":[46],"B)":[50],"461":[52],"men":[53,198],"women,":[55],"aged":[56],"\u226518":[57],"years":[58],"inadequate":[60],"glycaemic":[61,244],"control":[62],"(glycated":[63],"haemoglobin":[64],"[HbA1c]":[65],"concentration":[66],"7.0%":[67],"10.5%":[69],"[53-91":[70],"mmol/mol],":[71],"inclusive)":[72],"despite":[73],"diet":[74],"exercise.":[76],"Results":[77],"from":[78,95,111,179],"A":[80,189],"are":[81],"reported":[82],"present":[85],"paper.":[86],"The":[87,133,174],"primary":[88],"endpoint":[89],"change":[92],"HbA1c":[94,109,137],"baseline":[96,112,180],"week":[98,102],"26.":[99],"RESULTS:":[100],"At":[101],"26,":[103],"placebo-adjusted":[105,175],"least":[106],"squares":[107],"mean":[108],"changes":[110,178],"were":[113,141,185],"-0.99%":[114],"-1.16%":[116],"for":[117,130,239],"5":[120,147,234],"15":[122,149,236],"mg":[123,150,237],"doses,":[124],"respectively":[125],"(":[126],"P":[127],"<":[128],".001":[129],"both":[131],"doses).":[132],"odds":[134],"having":[136],"<7.0%":[138],"(53":[139],"mmol/mol)":[140],"significantly":[142,161],"greater":[143],"groups":[151],"compared":[152,204],"placebo":[155],"group.":[156],"Both":[157],"doses":[158],"lowered":[162],"fasting":[163],"plasma":[164],"glucose":[165,169],"2-hour":[167],"postprandial":[168],"levels":[170],"body":[172,247],"weight.":[173],"differences":[176],"systolic":[182],"blood":[183],"pressure":[184],"not":[186],"statistically":[187],"significant.":[188],"higher":[190],"incidence":[191],"genital":[193],"mycotic":[194],"infections":[195],"occurred":[196],"women":[200],"treated":[201],"placebo.":[206],"There":[207],"no":[209],"significant":[210],"difference":[211],"between":[212],"treatments":[213],"proportion":[216],"participants":[218],"symptomatic":[220],"hypoglycaemia":[221],"or":[222,230],"adverse":[223],"events":[224],"associated":[225],"urinary":[227],"tract":[228],"infection":[229],"hypovolaemia.":[231],"CONCLUSIONS:":[232],"Ertugliflozin":[233],"26":[240],"weeks":[241],"provides":[242],"effective":[243],"control,":[245],"reduces":[246],"weight":[248],"is":[250],"generally":[251],"well":[252],"tolerated,":[253],"when":[254],"used":[255],"as":[256],"monotherapy.":[257]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2581807473","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":19},{"year":2020,"cited_by_count":25},{"year":2019,"cited_by_count":26},{"year":2018,"cited_by_count":26},{"year":2017,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-02-03T00:00:00"}
